You are here: Industry Insights > GSK

News List

GSK links with Medicago to develop novel COVID-19 vaccine pharmatimes
July 09, 2020
GSK and Canadian biopharma Medicago are joining forces on the development and evaluation of a COVID-19 candidate vaccine combining the former's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system.
GSK partners with Medicago to develop plant-based Covid-19 vaccine pharmaceutical-technology
July 08, 2020
GlaxoSmithKline (GSK) has partnered with Canadian biopharmaceutical firm Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate.
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report expresspharma
July 07, 2020
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year, sooner than previously anticipated.
US FDA approves GSK’s HIV drug for patients with limited options expresspharma
July 06, 2020
The oral treatment from the company’s HIV unit, ViiV Healthcare, has been approved for adults whose HIV infection could not be successfully treated with other therapies due to resistance, intolerance or safety considerations.
Japan grants approval for GSK’s Duvroq to treat CKD-related anaemia pharmaceutical-technology
June 30, 2020
Japan’s Ministry of Health, Labour and Welfare has granted the first regulatory approval for GlaxoSmithKline (GSK)’s Duvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD).
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials worldpharmanews
June 29, 2020
GSK's scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.
GSK recalls three lots of children’s cough medicine in US europeanpharmaceuticalreview
June 24, 2020
GlaxoSmithKline has voluntarily recalled two lots of Children’s Robitussin® Honey Cough and Chest Congestion DM and one lot of Children’s Dimetapp® Cold and Cough in the US.
Sanofi eyes approval of COVID-19 vaccine by first half of 2021 expresspharma
June 24, 2020
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.
GSK/Clover's COVID-19 vaccine moves into human trials pharmatimes
June 23, 2020
GSK’s scientific collaboration with Chinese biotech Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine is now being tested in human clinical trials.
GSK and IDEAYA partner in synthetic lethality pharmatimes
June 18, 2020
GlaxoSmithKline and IDEAYA Biosciences have announced a strategic partnership in synthetic lethality, an emerging arm of oncology and a core research focus for GSK.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page